NCT03816319
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03816319
Title TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
Northwestern University RECRUITING Chicago Illinois 60611 United States Details
VCU Massey Comprehensive Cancer Center RECRUITING Richmond Virginia 23298 United States Details
University Health Network-Princess Margaret Hospital RECRUITING Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field